LifeScience Clinical & Diagnostic
Spain’s Ministry of Health Approves Access To Novocure’s TTFields Therapy For Newly Diagnosed Glioblastoma Patients
Eligible patients can receive TTFields therapy through the Spanish National Health System Novocure announced that Spain’s Ministry of Heal...
August 26, 2025 | News
Transforming Cancer Care in Japan and Asia-Pacific: Thermo Fisher’s Jane Li on Accelerating Precision Oncology with Next-Gen Diagnostics
BioPharma APAC spoke with Jane Li, Senior Director, Pharma CDx and CRO Partnership at Thermo Fisher Scientific, about the development of the Oncomine&trade...
August 25, 2025 | Expert Insight
SMSbiotech Launches First-in-Human Trial of Small Mobile Stem Cells for COPD in Australia
SMSbiotech, a San Diego–based leader in regenerative medicine, announced the initiation of its first-in-human Phase 1 clinical trial for C...
August 22, 2025 | News
BioDlink Secures Indonesian Approval for Bevacizumab, Accelerating ASEAN and Global Expansion
BioDlink announced that its Bevacizumab Injection has obtained marketing authorization from Indonesia's National Agency of Drug and Food Con...
August 22, 2025 | News
RemeGen and Santen Form Strategic Alliance on RC28-E for Asia and Greater China
RemeGen Co., a leading Chinese biopharmaceutical company, announced that it has entered into an agreement with Santen Pharmaceutical (China) Co., Ltd. ("Sa...
August 20, 2025 | News
Sanofi and AstraZeneca’s Beyfortus Receives HSA Approval to Prevent RSV in Infants
Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety ...
August 20, 2025 | Regulatory
Mabwell Secures FDA IND Clearance for CDH17-Targeting ADC 7MW4911 in Advanced GI Cancers
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D cod...
August 20, 2025 | News
Novo Nordisk’s Wegovy® Becomes First and Only GLP-1 Therapy Approved for MASH with Moderate to Advanced Fibrosis
Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with modera...
August 18, 2025 | News
Superluminal Medicines and Eli Lilly Forge $1.3 Billion Collaboration on Undisclosed GPCR Targets in Cardiometabolic Disease and Obesity
Collaboration focused on undisclosed GPCR targets Company to receive an upfront and near-term payments, including an equity investment, as...
August 15, 2025 | News
Daewoong Korea’s Semaglutide Patch Achieves 80 Percent Bioavailability to Transform Obesity Care
More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and...
August 14, 2025 | News
Remegen’s Telitacicept Hits Phase III Milestone in Primary Sjögren’s Syndrome
Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met the primary endp...
August 14, 2025 | News
Ascletis’ ASC47 Plus Tirzepatide Shows 87% Greater Weight Loss Than Tirzepatide Alone in Preclinical Obesity Study
The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in body weight compared to t...
August 13, 2025 | News
Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
Local health authorities reported thousands of cases within weeks; by early August, figures converged around the several-thousand mark, with some reports t...
August 11, 2025 | Analysis
“Spatial Biology at Scale: 10x Genomics CEO Serge Saxonov on Redefining Precision Medicine with TISHUMAP”
The future of medicine is being shaped at the intersection of spatial biology and artificial intelligence—and 10x Genomics is l...
August 07, 2025 | Interaction
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
